NeuroPace Inc (NPCE) stock
NPCENasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 6/3028% above fair value
$8.20+0.23 (+2.89%)
Close on Nov 17, 2026Market cap $281.46MP/E –Yield 0.00%
NeuroPace revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
NeuroPace's revenue for the twelve months ending Jun 30, 2026 was $98.84M, up 16.9% year over year. For fiscal 2025 it was $99.99M, up 25.1% from the year before. The highest annual figure on record is $99.99M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $99.99M | +25.1% |
| FY2024 | Dec 31, 2024 | $79.91M | +22.1% |
| FY2023 | Dec 31, 2023 | $65.42M | +43.7% |
| FY2022 | Dec 31, 2022 | $45.52M | +0.7% |
| FY2021 | Dec 31, 2021 | $45.18M | +9.8% |
| FY2020 | Dec 31, 2020 | $41.14M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $22.83M | +17.1% |
| Q1 FY2026 | Mar 31, 2026 | $22.07M | -2.0% |
| Q4 FY2025 | Dec 31, 2025 | $26.59M | +23.9% |
| Q3 FY2025 | Sep 30, 2025 | $27.35M | +29.9% |
| Q2 FY2025 | Jun 30, 2025 | $19.50M | +1.3% |
| Q1 FY2025 | Mar 31, 2025 | $22.52M | +24.3% |
| Q4 FY2024 | Dec 31, 2024 | $21.47M | +19.2% |
| Q3 FY2024 | Sep 30, 2024 | $21.06M | +28.2% |
| Q2 FY2024 | Jun 30, 2024 | $19.26M | +16.6% |
| Q1 FY2024 | Mar 31, 2024 | $18.12M | +25.2% |
| Q4 FY2023 | Dec 31, 2023 | $18.01M | +40.8% |
| Q3 FY2023 | Sep 30, 2023 | $16.43M | +47.2% |
| Q2 FY2023 | Jun 30, 2023 | $16.51M | +61.9% |
| Q1 FY2023 | Mar 31, 2023 | $14.47M | +27.2% |
| Q4 FY2022 | Dec 31, 2022 | $12.79M | +16.3% |
| Q3 FY2022 | Sep 30, 2022 | $11.16M | +7.9% |
| Q2 FY2022 | Jun 30, 2022 | $10.20M | -19.2% |
| Q1 FY2022 | Mar 31, 2022 | $11.37M | +1.4% |
| Q4 FY2021 | Dec 31, 2021 | $11.00M | +2.3% |
| Q3 FY2021 | Sep 30, 2021 | $10.34M | -19.0% |
| Q2 FY2021 | Jun 30, 2021 | $12.63M | +65.3% |
| Q1 FY2021 | Mar 31, 2021 | $11.22M | +12.5% |
| Q4 FY2020 | Dec 31, 2020 | $10.75M | – |
| Q3 FY2020 | Sep 30, 2020 | $12.77M | – |
| Q2 FY2020 | Jun 30, 2020 | $7.64M | – |
| Q1 FY2020 | Mar 31, 2020 | $9.98M | – |
See a number that looks wrong?